Overview: Rocky Mountain Spotted Fever Antibody TestIntroduction: The Rocky Mountain Spotted Fever Antibody Test detects RMSF antibodies to diagnose tick-borne infection, causing fever or rash. Following 2023 IDSA guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected Rocky Mountain spotted fever.
Other Names: RMSF Ab Assay, Rickettsia rickettsii Antibody Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: RMSF antibody testing began in the 1940s with tick-borne disease research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects RMSF antibodies to diagnose tick-borne infection, guides treatment, and evaluates patients with fever or rash.
Test Parameters: 1. RMSF Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, rash, or tick exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, rash, or history of tick exposure. Include current medications, especially doxycycline.
Consent: Written consent required, detailing the tests purpose, RMSF implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect RMSF IgG and IgM antibodies. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for RMSF diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or early testing can affect results. Cross-reactivity with other rickettsial infections may reduce specificity.
Clinical Significance: Positive IgM indicates acute RMSF, guiding doxycycline therapy. Positive IgG suggests past exposure, requiring clinical correlation.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: RMSF PCR, blood cultures, or skin biopsy to confirm RMSF diagnosis.
Test Limitations: Non-specific for certain rickettsial infections; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA RMSF Guidelines, 2023; Clinical Infectious Diseases, Chapman AS, 2022.
